Suppr超能文献

路易体疾病合并阿尔茨海默病共同病理改变时海马后部的保留:一项活体MRI研究

Posterior hippocampal sparing in Lewy body disorders with Alzheimer's copathology: An in vivo MRI study.

作者信息

Cohen Jesse S, Phillips Jeffrey, Das Sandhitsu R, Olm Christopher A, Radhakrishnan Hamsanandini, Rhodes Emma, Cousins Katheryn A Q, Xie Sharon X, Nasrallah Ilya M, Yushkevich Paul A, Wolk David A, Lee Edward B, Weintraub Daniel, Irwin David J, McMillan Corey T

机构信息

Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA; Department of Neurology, University of Florida, Jacksonville, FL, USA.

Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.

出版信息

Neuroimage Clin. 2025;45:103714. doi: 10.1016/j.nicl.2024.103714. Epub 2024 Dec 7.

Abstract

BACKGROUND

Lewy body disorders (LBD), encompassing Parkinson disease (PD), PD dementia (PDD), and dementia with Lewy bodies (DLB), are characterized by alpha-synuclein pathology but often are accompanied by Alzheimer's disease (AD) neuropathological change (ADNC). The medial temporal lobe (MTL) is a primary locus of tau accumulation and associated neurodegeneration in AD. However, it is unclear the extent to which AD copathology in LBD (LBD/AD+) contributes to MTL-specific patterns of degeneration. We employ a MTL subregional segmentation strategy of T1-weighted (T1w) MRI in biomarker-supported or autopsy-confirmed LBD and LBD/AD+ to investigate the anatomic consequences of co-occurring LBD/AD+ pathology on neurodegeneration.

METHODS

We studied 167 individuals with clinical diagnoses of LBD (PD, n = 124 (74.3 %); PDD, n = 11 (6.6 %); DLB, n = 32 (19.2 %)) with available T1w MRI and AD biomarkers or autopsy evidence of ADNC. Individuals were further biologically classified as LBD/AD+ based on hierarchical evidence of ADNC pathology: 1) AD "intermediate" or "high" by ABC neuropathologic criteria (n = 39 (23.4 %)); 2) positive amyloid PET (n = 2 (1.2 %)); or 3) CSF β-amyloid < 185.7 pg/mL n = 126 (75.4 %)). The T1 Automated Segmentation of Hippocampal Subfields (ASHS) pipeline was used to compute volume and thickness measurements of MTL subregions in LBD/AD- and LBD/AD+. Linear regression tested the association of AD copathology and subregion volume/thickness, covarying for age and sex, and intracranial volume for volume measurements. Secondary analyses correlated MTL subregional volume/thickness with cognition and neuropathology.

RESULTS

LBD/AD+ had decreased volume/thickness compared to LBD/AD- in all MTL subregions except posterior hippocampus. The greatest effect sizes were seen in Brodmann Area 35 (BA35) (Cohen's d = 0.62, p = 0.002, β = 0.107 ± 0.034), and entorhinal cortex (ERC) (Cohen's d = 0.56, p = 0.006, β = 0.088 ± 0.031). Smaller differences were seen in the parahippocampal cortex (PHC) (Cohen's d = 0.5, p = 0.012, β = 0.082 ± 0.033), BA36 (Cohen's d = 0.47, p = 0.021, β = 0.090 ± 0.039) and anterior hippocampus (Cohen's d = 0.45, p = 0.029, β = 111.790 ± 50.595). Verbal memory scores positively correlated with volume/thickness in anterior and posterior hippocampus, BA35, ERC and PHC, while visuospatial memory positively correlated only in BA35. In the subset of participants with autopsy, lower ERC volume was associated with a higher tau load in ERC (adjusted odds ratio 0.013, 95 % CI [0.0002, 0.841], uncorrected p = 0.041).

CONCLUSIONS

Relative to LBD/AD-, LBD/AD+ has greater T1w MRI evidence of atrophy in multiple MTL subregions. Atrophy in MTL subregions associates with memory performance and tau pathological load. The observed pattern of atrophy largely follows expectation from AD Braak stages, except for posterior hippocampus. Longitudinal studies are needed to validate the hypothesized spread of neurodegeneration.

摘要

背景

路易体障碍(LBD)包括帕金森病(PD)、帕金森病痴呆(PDD)和路易体痴呆(DLB),其特征为α-突触核蛋白病理改变,但常伴有阿尔茨海默病(AD)神经病理改变(ADNC)。内侧颞叶(MTL)是AD中tau蛋白积累和相关神经变性的主要部位。然而,尚不清楚LBD中的AD共病病理(LBD/AD+)在多大程度上导致MTL特定的变性模式。我们采用T1加权(T1w)MRI的MTL亚区域分割策略,对生物标志物支持或尸检证实的LBD和LBD/AD+进行研究,以探讨LBD/AD+共病病理对神经变性的解剖学影响。

方法

我们研究了167例临床诊断为LBD的个体(PD,n = 124(74.3%);PDD,n = 11(6.6%);DLB,n = 32(19.2%)),这些个体有可用的T1w MRI以及AD生物标志物或ADNC的尸检证据。根据ADNC病理的分级证据,个体被进一步生物学分类为LBD/AD+:1)ABC神经病理标准为AD“中度”或“高度”(n = 39(23.4%));2)淀粉样蛋白PET阳性(n = 2(1.2%));或3)脑脊液β-淀粉样蛋白<185.7 pg/mL(n = 126(75.4%))。使用海马亚区域T1自动分割(ASHS)管道计算LBD/AD-和LBD/AD+中MTL亚区域的体积和厚度测量值。线性回归检验了AD共病病理与亚区域体积/厚度的关联,对年龄、性别进行协变量调整,并对体积测量值的颅内体积进行协变量调整。二次分析将MTL亚区域体积/厚度与认知和神经病理学进行关联。

结果

与LBD/AD-相比,LBD/AD+在除后海马以外的所有MTL亚区域的体积/厚度均降低。在布罗德曼区35(BA35)(科恩d值 = 0.62,p = 0.002,β = 0.107±0.034)和内嗅皮质(ERC)(科恩d值 = 0.56,p = 0.006,β = 0.088±0.031)中观察到最大效应量。在海马旁皮质(PHC)(科恩d值 = 0.5,p = 0.012,β = 0.082±0.033)、BA36(科恩d值 = 0.47,p = 0.021,β = 0.090±0.039)和前海马(科恩d值 = 0.45,p = 0.029,β = 111.790±50.595)中观察到较小差异。言语记忆评分与前海马和后海马、BA35、ERC和PHC的体积/厚度呈正相关,而视觉空间记忆仅与BA35呈正相关。在尸检参与者的子集中,较低的ERC体积与ERC中较高的tau负荷相关(调整后的优势比为0.013,95%可信区间[0.0002, 0.841],未校正p = 0.041)。

结论

相对于LBD/AD-,LBD/AD+在多个MTL亚区域有更多T1w MRI萎缩证据。MTL亚区域萎缩与记忆表现和tau病理负荷相关。观察到的萎缩模式在很大程度上符合AD Braak分期的预期,但后海马除外。需要进行纵向研究来验证假设的神经变性传播。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16ca/11713745/82aa2029d4df/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验